ProVascTec Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 5

ProVascTec General Information

Description

Operator of a cell therapy company intended to positively impact the lives of patients suffering from cardiovascular complications. The company leverages the paracrine mechanism of stem cells to induce the growth of a novel vascular system, creating a natural bypass around arterial occlusions in the peripheral vascular system, specifically below the knee, providing healthcare professionals with a proprietary local delivery device.

Contact Information

Website
www.provasctec.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • GatewayUCC Business Incubation Hub
  • Unit 3.23 Food Science Building University College Cork
  • Cork T12 CY82
  • Ireland
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Drug Delivery
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • GatewayUCC Business Incubation Hub
  • Unit 3.23 Food Science Building University College Cork
  • Cork T12 CY82
  • Ireland

ProVascTec Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProVascTec Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC 17-Jul-2025 Completed Pre-Clinical Trials
6. Accelerator/Incubator 22-Aug-2024 Completed Pre-Clinical Trials
5. Equity Crowdfunding Completed Pre-Clinical Trials
4. Accelerator/Incubator 26-Sep-2023 Completed Startup
3. Early Stage VC 08-Mar-2023 Completed Startup
2. Seed Round 16-Apr-2021 Completed Startup
1. University Spin-Out 01-Jan-2021 Completed Startup
To view ProVascTec’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

ProVascTec Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ProVascTec Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Eurostars Other Minority
Creative Destruction Lab Accelerator/Incubator
Enterprise Ireland Growth/Expansion Minority
NLC Health Ventures Venture Capital Minority
University College Cork University
To view ProVascTec’s complete investors history, request access »

Ready to get started?

Request a free trial

ProVascTec FAQs

  • When was ProVascTec founded?

    ProVascTec was founded in 2021.

  • Where is ProVascTec headquartered?

    ProVascTec is headquartered in Cork, Ireland.

  • What is the size of ProVascTec?

    ProVascTec has 3 total employees.

  • What industry is ProVascTec in?

    ProVascTec’s primary industry is Drug Discovery.

  • Is ProVascTec a private or public company?

    ProVascTec is a Private company.

  • What is ProVascTec’s current revenue?

    The current revenue for ProVascTec is .

  • How much funding has ProVascTec raised over time?

    ProVascTec has raised $3.49M.

  • Who are ProVascTec’s investors?

    Eurostars, Creative Destruction Lab, Enterprise Ireland, NLC Health Ventures, and University College Cork have invested in ProVascTec.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process